Alfuzosin HCL ER 10 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FDAXN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,818
Award facts
- Contract value 100% obligated
- $3,817.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $3,817.50 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Alfuzosin HCL ER 10 mg tablets (90-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of September 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that provides comprehensive global pharmaceutical support for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply diverse pharmaceutical products including brand-name and generic medications across multiple therapeutic domains. Through its prime IDC with DLA Troop Support Medical, AmerisourceBergen supplies pharmaceutical products and medical commodities to support Defense Health Agency operations and other government healthcare systems worldwide. The company's competitive award status and track record of fulfilling federal medical supply requirements across varying transaction values underscore its position as a key healthcare solutions provider within the federal procurement landscape.
Quick answers
Who was awarded contract SPE2DB25FDAXN?
SPE2DB25FDAXN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FDAXN worth?
The government has obligated $3,818 on SPE2DB25FDAXN.
Is contract SPE2DB25FDAXN an order under another contract?
Yes. SPE2DB25FDAXN is a delivery order under SPE2DB24D1205, an indefinite delivery contract.
Was contract SPE2DB25FDAXN competed?
The extent of competition for SPE2DB25FDAXN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award